Etesian Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Etesian Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Hold	766	–	–	0.12%	103
2025 Q4	$444K	Sell	766 -20	-3%	-$11.3K	0.14%	99
2025 Q3	$381K	Sell	786 -8	-1%	-$3.72K	0.13%	108
2025 Q2	$322K	Sell	794 -19	-2%	-$7.94K	0.12%	110
2025 Q1	$405K	Sell	813 -50	-6%	-$27.1K	0.17%	104
2024 Q4	$449K	Hold	863	–	–	0.2%	103
2024 Q3	$534K	Hold	863	–	–	0.24%	97
2024 Q2	$477K	Hold	863	–	–	0.27%	92
2024 Q1	$502K	Sell	863 -15	-2%	-$8.42K	0.29%	89
2023 Q4	$468K	Sell	878 -25	-3%	-$12.1K	0.28%	88
2023 Q3	$457K	Sell	903 -13	-1%	-$6.93K	0.31%	86
2023 Q2	$478K	Sell	916 -9	-1%	-$4.86K	0.31%	85
2023 Q1	$533K	Sell	925 -50	-5%	-$28.2K	0.35%	83
2022 Q4	$537K	Buy	+975	New	+$517K	0.39%	79

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Etesian Wealth Advisors's TMO Position: Q1 2026 in Review

Etesian Wealth Advisors held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 766 shares worth $377K. The position accounts for 0.12% of the portfolio, ranked #103.

Etesian Wealth Advisors first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $537K in Q4 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Etesian Wealth Advisors held 766 shares of Thermo Fisher Scientific worth $377K as of Q1 2026.
Etesian Wealth Advisors left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.12% of Etesian Wealth Advisors's portfolio in Q1 2026, its #103 holding.
Etesian Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Etesian Wealth Advisors's Thermo Fisher Scientific position peaked at $537K in Q4 2022.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Etesian Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.